Cowen Initiates Coverage on Puma Biotechnology (PBYI)
News | 13 November 2012
Equities research analysts at Cowen initiated coverage on shares of Puma Biotechnology (NASDAQ: PBYI) in a research note issued to investors on Tuesday. The firm set an ?outperform? rating on the stock. A number of other analysts have also recently ...
Click on the link to read the full article at Daily Political
(This link will open in a new window)
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
